|
Volumn 65, Issue 12, 2005, Pages 1964-1966
|
Immune response to influenza vaccine is maintained in patients with multiple sclerosis receiving interferon beta-1a
b
SANOFI PASTEUR
(France)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA1A INTERFERON;
INFLUENZA VACCINE;
ANTIBODY;
BETA INTERFERON;
IMMUNOLOGICAL ADJUVANT;
ADULT;
ARTICLE;
BLOOD SAMPLING;
CHRONIC DRUG ADMINISTRATION;
CONTROLLED STUDY;
FEMALE;
HEMAGGLUTINATION INHIBITION TEST;
HUMAN;
IMMUNE RESPONSE;
INFLUENZA VACCINATION;
INJECTION SITE PAIN;
MAJOR CLINICAL STUDY;
MALE;
MULTIPLE SCLEROSIS;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
BLOOD;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG INTERACTION;
IMMUNITY;
IMMUNOLOGY;
INFLUENZA;
MIDDLE AGED;
TREATMENT OUTCOME;
ADJUVANTS, IMMUNOLOGIC;
ADULT;
ANTIBODIES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG INTERACTIONS;
FEMALE;
HEMAGGLUTINATION INHIBITION TESTS;
HUMANS;
IMMUNITY;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
INTERFERON-BETA;
MALE;
MIDDLE AGED;
MULTIPLE SCLEROSIS;
PROSPECTIVE STUDIES;
TREATMENT OUTCOME;
|
EID: 33645738006
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/01.wnl.0000188901.12700.e0 Document Type: Article |
Times cited : (60)
|
References (8)
|